| Name | Title | Contact Details |
|---|
FOREO is a Swedish multi-national beauty brand established and headquartered Stockholm, Sweden.
Physicians Health Choice is a San Antonio, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Senior Whole Health is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Senior Whole Health is based in Cambridge, MA. You can find more information on Senior Whole Health at www.seniorwholehealth.com
Community Health Resources` (CHR) mission is to help adults, children and families find Real Hope for the challenges of Real Life through an array of community based mental health, substance use, child welfare, supported housing, foster care, prevention and wellness services and integrated care. Our name embodies our commitment to community based care, utilizing all available resources to achieve change, and instill hope for a healthy, happy and productive future. CHR is proud to provide services that achieve Real Quality with Real Results. CHR’s history dates back to the 1960s, and since its creation, has become a trusted community resource and well-respected service provider. We employ over 700 experienced staff members who provided services to more than 18,000 individuals in the past year. We offer effective, accesible and affordable behavioral healthcare through 80 programs and 32 locations. As we anticipate changing needs, we will offer new programs, recruit exceptional staff, collaborate with other providers, and explore new funding sources. The driving force of our growth continues to be meeting the needs of those we serve.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.